You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
环亚国际医疗集团(01143.HK)2020年净亏同比扩大12.59%至1.93亿港元
格隆汇 04-01 00:44

格隆汇 4 月 1日丨环亚国际医疗集团(01143.HK)公告,截至2020年12月31日止年度未经审核年度业绩,收入约为5.95亿港元(单位下同),同比减少5.54%;公司拥有人应占亏损约为1.93亿港元,同比扩大12.59%;每股基本亏损51.529港仙;不派息。

在严峻的经营环境下,集团的电子制造服务及分销通讯产品分部录得业绩下滑,收入减少约6.3%。

集团启用双重策略,从而推动未来收入更快、更稳定地增长。作为该策略的一部分,集团于2021年初正式将由"环亚国际实业有限公司"更名为"环亚国际医疗科技集团有限公司",凸显集团致力成为医疗科技集团的愿景,并提供包括相关产品及服务在内的辅助生殖技术,以满足亚太区特别是中国内地高端客户的生育需求。

与此同时,集团进入利润丰厚且住房需求巨大的东南亚房地产市场。为此,集团自2019年下半年起已利用其业务网络在该地区物色优质房地产项目。当下的疫情限制航空旅行并扰乱供应链,当疫情于2021年出现缓解迹象时,公司将进一步加大物色力度。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account